homeBiocon Biologics News
Biocon Biologics NEWS
market | Mar 28, 2024 8:01 AM ISTBiocon becomes the first generics company to get a diabetes drug approval in the UK
business | Mar 15, 2024 5:48 PM ISTBiocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting
healthcare | Mar 4, 2024 9:46 AM ISTBiocon Biologics gets Canada market entry date for ophthalmic drug Yesafili
- healthcare | Dec 22, 2023 5:36 PM IST
Biocon Biologics, Sandoz ink deal to market immune disorder injection adalimumab in Japan
healthcare | Dec 18, 2023 5:07 PM ISTBiocon Biologics takes charge of Viatris' biosimilars across 120 countries
healthcare | Nov 13, 2023 5:08 PM ISTBiocon Biologics receives UK regulator's approval for ophthalmic drug YESAFILI
business | Nov 8, 2023 4:55 PM ISTBiocon to sell two non-core India business units to Eris Lifesciences
business | Oct 19, 2023 4:17 PM ISTBiocon Biologics appoints Kedar Upadhye as new CFO, MB Chinappa to take on strategic finance role
- market | Oct 18, 2023 8:47 AM IST
Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection
healthcare | Sept 20, 2023 6:48 PM ISTBiocon Biologics' critical eye treatment medicine YESAFILI gets European Commission nod
healthcare | Sept 20, 2023 2:33 PM ISTKiran Mazumdar Shaw stresses strategic significance of Peter Bains' appointment as Biocon group CEO
business | Sept 18, 2023 7:47 PM ISTBiocon appoints Peter Bains as group CEO to drive 'synergistic' growth
- healthcare | Sept 7, 2023 5:01 PM IST
Biocon Biologics may reveal details of its likely IPO post integration of the acquired biosimilar business
business | Aug 4, 2023 5:41 PM ISTBiocon Biologics announces key appointments to leadership team
healthcare | Jul 3, 2023 11:53 PM ISTBiocon Biologics biosimilar to treat certain inflammatory diseases now available in US market